Reneo Pharmaceuticals Stock (NASDAQ: RPHM) stock price, news, charts, stock research, profile.
Open | $1.46 |
Close | - |
Volume / Avg. | 16.03K / 275.31K |
Day Range | 1.46 - 1.51 |
52 Wk Range | 0.98 - 9.21 |
Market Cap | $49.13M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 18.5% |
Days to Cover | 31.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Reneo Pharmaceuticals (NASDAQ:RPHM) through any online brokerage.
Other companies in Reneo Pharmaceuticals’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS) and BioLine Rx (NASDAQ:BLRX).
There is no analysis for Reneo Pharmaceuticals.
Reneo Pharmaceuticals has a consensus price target of $17.39.
The stock price for Reneo Pharmaceuticals (NASDAQ: RPHM) is $1.48 last updated Today at July 9, 2024 at 10:54 AM EDT.
There are no upcoming dividends for Reneo Pharmaceuticals.
Reneo Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Reneo Pharmaceuticals.
Reneo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.